These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7190431)

  • 1. [In vivo drug release from microencapsulated acetylsalicylic acid with simultaneous alcohol uptake].
    Frömming KH; Schwabe L
    Arzneimittelforschung; 1980; 30(5):836-9. PubMed ID: 7190431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influence of ethanol on the in vitro and in vivo drug release from some sustained release tablets (author's transl)].
    Frömming KH; Topaloglu Y
    Arzneimittelforschung; 1975; 25(12):1958-64. PubMed ID: 3188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The study of the bioavailability of coated acetylsalicylic acid in suppositories after rectal administration.
    Stozek T
    Pol J Pharmacol Pharm; 1975; 27(2):227-33. PubMed ID: 1153355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cimetidine on bioavailability of enteric-coated aspirin tablets.
    Paton TW; Walker SE; Leung FY; Little AH
    Clin Pharm; 1983; 2(2):165-6. PubMed ID: 6883946
    [No Abstract]   [Full Text] [Related]  

  • 5. Steady-state salicylate plasma and urinary metabolite concentrations from plain, buffered, or enteric-coated aspirin.
    Allen JH; Thakker KM; Small RE; Wood JH; Willis HE
    Clin Pharm; 1983; 2(1):64-6. PubMed ID: 6883933
    [No Abstract]   [Full Text] [Related]  

  • 6. [The rate of the in vitro dissolution of microencapsulated acetylsalicylic acid (Colfarit) in relation to the ethanol content of the dissolution medium (author's transl)].
    Frömming KH; Schwabe L
    Arch Pharm (Weinheim); 1976 Dec; 309(12):995-1000. PubMed ID: 1021030
    [No Abstract]   [Full Text] [Related]  

  • 7. [Biopharmaceutical evaluation of some tablets of acetylsalicylic acid. Importance of the method of dissolution in the establishment of the in vivo and in vitro correlations].
    Doelker E; Schwyter H; Mordier D
    Pharm Acta Helv; 1975; 50(1-2):24-7. PubMed ID: 1114158
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative bioavailability of sustained-release and uncoated aspirin tablets.
    Karahalios WJ; Sawyer WT; Rittase RA; Maynard SA
    Am J Hosp Pharm; 1981 Nov; 38(11):1754-6. PubMed ID: 7304632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microencapsulated acetylsalicylic acid. An automatic spectrophotometric method for release determination.
    Bongiovanni G; Giani C; Innocenti F; Maccari M; Pogliano L
    Boll Chim Farm; 1982 Mar; 121(3):106-16. PubMed ID: 7126349
    [No Abstract]   [Full Text] [Related]  

  • 10. [The influence of six alcoholic beverages on ethanol concentration in the blood and breath].
    Hey H; Haslund-Vinding P
    Ugeskr Laeger; 2006 Jan; 168(5):470-5. PubMed ID: 16472436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained release aspirin.
    Pomare EW; Treadwell BL
    N Z Med J; 1971 Mar; 73(466):139-43. PubMed ID: 4930820
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of salicylates administered with metoprolol.
    Spahn H; Langguth P; Kirch W; Mutschler E; Ohnhaus EE
    Arzneimittelforschung; 1986 Nov; 36(11):1697-9. PubMed ID: 3814230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific alcoholic beverage and blood pressure in a middle-aged Japanese population: the High-risk and Population Strategy for Occupational Health Promotion (HIPOP-OHP) Study.
    Okamura T; Tanaka T; Yoshita K; Chiba N; Takebayashi T; Kikuchi Y; Tamaki J; Tamura U; Minai J; Kadowaki T; Miura K; Nakagawa H; Tanihara S; Okayama A; Ueshima H;
    J Hum Hypertens; 2004 Jan; 18(1):9-16. PubMed ID: 14688805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo evaluation of riboflavin-containing microballoons for a floating controlled drug delivery system in healthy humans.
    Sato Y; Kawashima Y; Takeuchi H; Yamamoto H
    Int J Pharm; 2004 May; 275(1-2):97-107. PubMed ID: 15081141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability of sustained-release aspirin preparations.
    Lobeck F; Spigiel RW
    Clin Pharm; 1986 Mar; 5(3):236-8. PubMed ID: 3956130
    [No Abstract]   [Full Text] [Related]  

  • 16. [Determination of the salicylate level in plasma after administration of acetylsalicylic acid as well as a combination of acetylsalicylic acid and ascorbic acid].
    Staudacher HL; Müller H
    Arzneimittelforschung; 1969 Sep; 19(9):1612-3. PubMed ID: 5394538
    [No Abstract]   [Full Text] [Related]  

  • 17. Superior efficacy of clopidogrel plus acetylsalicylic acid compared with extended-release dipyridamole plus acetylsalicylic acid in preventing arterial thrombogenesis in healthy volunteers.
    Cadroy Y; Thalamas C; Sakariassen K; Boneu B
    Thromb Res; 2005; 116(4):293-300. PubMed ID: 16038713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Absorption studies on salicylates. 1. Absorption of acetylsalicylic acid after oral application].
    Pütter J; Bauer K
    Arzneimittelforschung; 1970 Nov; 20(11):1718-20. PubMed ID: 5536978
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of three slow-release acetylsalicylic acid preparations in rheumatoid arthritis.
    Martio J; Kahela P
    Scand J Rheumatol; 1983; 12(3):305-9. PubMed ID: 6623020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma salicylate concentrations following chronic administration of aspirin as conventional and sustained-release tablets.
    Wiseman EH
    Curr Ther Res Clin Exp; 1969 Nov; 11(11):681-9. PubMed ID: 4982303
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.